Institutional investors purchased a net $12.0 million shares of ZIOP during the quarter ended December 2013, and now own 36.01% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BELMONT GLOBAL ADVISORS, INC. Bought 2.6 Million shares of ZIOPHARM Oncology Inc
SSGA FUNDS MANAGEMENT, INC. Bought 2.3 Million shares of ZIOPHARM Oncology Inc
JENNISON ASSOCIATES LLC Bought 1.9 Million shares of ZIOPHARM Oncology Inc